US2022025404A1PendingUtilityA1
Compositions and methods for monitoring in real-time construction and bioengineering of mammalian synthetic chromosomes
Est. expiryFeb 9, 2035(~8.5 yrs left)· nominal 20-yr term from priority
C12N 15/90C12N 15/63C12N 2800/208C07K 2319/60
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention encompasses compositions and methods to allow one to monitor formation of synthetic chromosomes in real-time via standardized fluorescent technology, eliminating the need for cumbersome, expensive, and possibly mutagenic analysis.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A mammalian synthetic chromosome production host cell line for tracking synthetic chromosome production in real-time, comprising:
(i) an endogenous chromosome tag that labels one or more endogenous chromosomes in the chromosome production host cell line; and (ii) a differently-labeled synthetic chromosome tag that identifies, apart from the endogenous chromosomes, a synthetic chromosome as it is being produced, wherein the endogenous chromosome tag and synthetic chromosome tag are stably integrated into the synthetic chromosome production host cell line's genome.
2 . The host cell line of claim 1 , wherein an arm of an endogenous chromosome comprises a recombination site compatible for interaction with a recombination site in the synthetic chromosome.
3 . The host cell line of claim 1 , comprising a fully-functional mammalian synthetic chromosome.
4 . The host cell line comprising the synthetic chromosome of claim 3 , wherein the synthetic chromosome-specific tag is stably integrated into the synthetic chromosome.
5 . The host cell line comprising the synthetic chromosome of claim 3 , wherein both the endogenous chromosome tag and the synthetic chromosome-specific tag are stably integrated into the synthetic chromosome.
6 . The host cell line comprising the synthetic chromosome of claim 3 , wherein the endogenous chromosome tag has been stably integrated into the synthetic chromosome and the synthetic chromosome-specific tag has been stably integrated into the synthetic chromosome production host cell line's genome.
7 . The host cell line of claim 1 , wherein the endogenous chromosome tag and the synthetic chromosome-specific tag comprise fluorescent tags, and the monitoring step is performed by fluorescence microscopy.
8 . The host cell line of claim 7 , wherein the fluorescent tags are selected from TagBFP, TagCFP, TagGFP2, TagYFP, TagRFP, FusionRed, mKate2, TurboGFP, TurboYFP, TurboRFP, TurboFP602, TurboFP635, TurboFP650, AmCyan1, AcvGFP1, ZsGreen1, ZsYellow1, mBanana, mOrange, mOrange2, DsRed-Express2, DsRed-Express, tdTomato, DsRed-Monomer, DsRed2, AsRed2, mStrawberry, mCherry, HcRed1, mRaspberry, E2-Crimson, mPlum, Dendra 2, Timer, PAmCherry, HALO-tags, infrared-shifted fluorescent proteins, and the like.
9 . The host cell line of claim 1 , wherein the tags of the endogenous chromosome tag and the synthetic chromosome-specific tag comprise:
(i) chemiluminescent tags and the monitoring step is performed by chemiluminescent microscopy, or (ii) phosphorescent tags and the monitoring step is performed by phosphorescent microscopy.
10 . The host cell line of claim 1 , wherein the endogenous chromosome tag comprises a marker specific to histones H1, H2A, H2B, H3, H4, or H5.
11 . The host cell line of claim 1 , wherein the synthetic chromosome-specific tag comprises 4 n nucleotides that have been screened against a database of known sequences.
12 . The host cell line of claim 1 , wherein the cell line is selected from an animal cell line, a plant cell line, a mammalian cell line, a rodent cell line, a zebrafish cell line, an embryonic cell line, a pluripotent cell line, an adult-derived stem cell, a reprogrammed cell line and a human cell line.
13 . The host cell line of claim 12 , wherein the human cell line is HT1080.
14 . The host cell line of claim 1 , wherein the cell line produces synthetic chromosomes via an approach selected from: a top down approach, a bottom up approach, engineering of naturally occurring minichromosomes, or de novo chromosome generation by targeted amplification of chromosomal segments.
15 . The host cell line of claim 14 , wherein the cell line produces synthetic chromosomes via de novo chromosome generation by targeted amplification of pericentric chromosomal segments.
16 . The host cell line of claim 1 , wherein the endogenous chromosome tag comprises a plurality of endogenous chromosome tags.
17 . The host cell line of claim 1 , wherein the endogenous chromosome tag is a fusion protein, nucleic acid/protein chimera, nucleic acid/protein complex, a RNA/CRISPR-CAS9 complex, or a moiety comprising a TALEN protein specific to the endogenous chromosomes, and a fluorescent or phosphorescent label.
18 . The host cell line of claim 1 , further comprising one or more of: an endogenous chromosome binding moiety; a first reporter moiety; a second reporter moiety; a synthetic chromosome binding moiety; and a selectable marker.
19 . A fully-functional mammalian synthetic chromosome, produced by transfection of synthetic chromosome production components into the host cell line of claim 1 .
20 . The fully-functional mammalian synthetic chromosome of claim 19 , wherein the synthetic chromosome is 1-120 Mbp in size.Join the waitlist — get patent alerts
Track US2022025404A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.